Personalized medicine: paradigm shift in ALK positive non-small cell lung cancer: a case report
Abstract Background Since the identification of multiple therapeutic targets, as is the case of anaplastic lymphoma kinase (ALK) translocation, the paradigm of treating patients with non-small cell lung cancer (NSCLC) has improved. In order to guarantee the possibility of longer survival outcomes wi...
Furkejuvvon:
| Váldodahkkit: | , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
BMC
2023-09-01
|
| Ráidu: | Journal of Medical Case Reports |
| Fáttát: | |
| Liŋkkat: | https://doi.org/10.1186/s13256-023-04107-5 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|